Cefaclor

Product Monograph: Cefaclor Cefaclor is a second-generation cephalosporin antibiotic, classified as a beta-lactam antimicrobial agent. It belongs to the broader family of cephalosporins, which are bactericidal drugs derived from the fungus Acremonium. Cefaclor was developed as a semi-synthetic oral antibiotic, designed to offer a broader spectrum of activity and improved stability against bacterial beta-lactamase enzymes compared to some first-generation agents like cephalexin. Its primary role in modern medicine is to serve as a key therapeutic option for treating mild to moderate community-acquired bacterial infections, particularly those of the respiratory tract, skin, and urinary system.